Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Mastocytoses, Indolent”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Large-scale testing (Phase 3)UnknownNCT04333108
What this trial is testing

Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment

Who this might be right for
Indolent Systemic Mastocytosis
AB Science 140
Not applicableUnknownNCT05923372
What this trial is testing

Evaluation of the DALY on a Cohort of Patients With Indolent Systemic Mastocytosis

Who this might be right for
Mastocytosis, Indolent Systemic
University Hospital, Toulouse 160
Not applicableLooking for participantsNCT07255638
What this trial is testing

A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany

Who this might be right for
Indolent Systemic Mastocytosis
Blueprint Medicines Corporation 80
Not applicableStudy completedNCT02620254
What this trial is testing

Mast Cell Connect: A Registry for Patients With Mastocytosis

Who this might be right for
Mastocytosis
Blueprint Medicines Corporation 743
Testing effectiveness (Phase 2)UnknownNCT04655118
What this trial is testing

Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis

Who this might be right for
MyelofibrosisIndolent Systemic Mastocytosis
Telios Pharma, Inc. 121
Testing effectiveness (Phase 2)Active Not RecruitingNCT05186753
What this trial is testing

(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis

Who this might be right for
SSMMastocytosis, IndolentMastocytosis, Systemic+5 more
Cogent Biosciences, Inc. 237
Testing effectiveness (Phase 2)UnknownNCT01920204
What this trial is testing

Midostaurin in Indolent Systemic Mastocytosis

Who this might be right for
Indolent Systemic Mastocytosis
University Medical Center Groningen 20
Not applicableLooking for participantsNCT07264959
What this trial is testing

An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)

Who this might be right for
Indolent Systemic Mastocytosis
Blueprint Medicines Corporation 150
Not applicableStudy completedNCT03632811
What this trial is testing

Adaptation of the Questionnaire "Regarding Patient's Quality of Life With Mastocytosis" in the French Language

Who this might be right for
Cutaneous MastocytosisIndolent Systemic Mastocytosis
University Hospital, Toulouse 30
Post-approval studies (Phase 4)Looking for participantsNCT06748001
What this trial is testing

Avapritinib Rollover Study

Who this might be right for
Mastocytosis, Systemic
Blueprint Medicines Corporation 60
Large-scale testing (Phase 3)Study completedNCT00814073
What this trial is testing

Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis

Who this might be right for
Indolent Systemic Mastocytosis
AB Science 135
Large-scale testing (Phase 3)UnknownNCT05084872
What this trial is testing

Hydroxychloroquine in Isolated Cutaneous Mastocytosis Patients or Indolent Systemic Mastocytosis With Associated Skin Involvement Patients

Who this might be right for
Mastocytosis
University Hospital, Toulouse 30
Testing effectiveness (Phase 2)Study completedNCT03770273
What this trial is testing

Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis

Who this might be right for
Indolent Systemic Mastocytosis
National Institute of Allergy and Infectious Diseases (NIAID) 21
Not applicableAvailableNCT06915766
What this trial is testing

Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis

Who this might be right for
Systemic Mastocytoses, IndolentSystemic Mastocytoses, Aggressive
Cogent Biosciences, Inc.
Large-scale testing (Phase 3)Looking for participantsNCT04910685
What this trial is testing

(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

Who this might be right for
Indolent Systemic MastocytosisSmoldering Systemic Mastocytosis
Blueprint Medicines Corporation 534
Not applicableStudy completedNCT02380222
What this trial is testing

Patient-Reported Outcome Questionnaire for Systemic Mastocytosis

Who this might be right for
Aggressive Systemic Mastocytosis (ASM)SM w Assoc Clonal Hema Non-mast Cell Lineage Disease (SM-AHNMD)Mast Cell Leukemia (MCL)+2 more
Adelphi Values LLC 5
Testing effectiveness (Phase 2)Study completedNCT00831974
What this trial is testing

Efficacy of AB1010 in Patients With Systemic Indolent Mastocytosis

Who this might be right for
Mastocytosis
AB Science 23
Early research (Phase 1)Study completedNCT02808793
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002

Who this might be right for
Indolent Systemic Mastocytosis
Allakos Inc. 25
Testing effectiveness (Phase 2)Study completedNCT02478957
What this trial is testing

Treatment of Indolent Systemic Mastocytosis With PA101

Who this might be right for
MastocytosisSystemic MastocytosisIndolent Systemic Mastocytosis
Patara Pharma 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT03731260
What this trial is testing

(PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent Systemic Mastocytosis

Who this might be right for
Indolent Systemic Mastocytosis
Blueprint Medicines Corporation 251
Next Page